This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated HDAC7 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HDAC7 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~102.9 kDa | |
| Observed band | ~103 kDa | |
| Gel | 8–10% | |
| Negative control | siRNA / KO lysate |
| PTM | Phosphorylated | |
| Caveat | Multiple isoforms | |
| Regulation | IFN-γ-induced | |
| Isoform | 10 isoform(s) |
Literature-validated Western blot parameters for HDAC7 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | Rat Spleen at 50ug, Lane 2: Rat Thymus at 50ug, Lane 3: Human Placenta at 50ug, Lane 4: HELA at 40ug. After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-HDAC7 antigen affinity purified polyclonal antibody (Catalog # PB9629) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for HDAC7 at approximately 103 kDa. The expected band size for HDAC7 is at 103 kDa |
| Gel % | 8–10% |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 103 kDa |
HDAC7 has a 102.9 kDa predicted backbone and is empirically observed at ~103 kDa, closely matching since it lacks glycosylation, cleavage, or dimerization that would shift its mass.
| single sharp band at approximately 103 kDa | matches HDAC7's predicted 102.9 kDa mass with no glycosylation, disulfide dimerization, or proteolytic cleavage to shift it |
| band running slightly diffuse or marginally above the core 103 kDa position | reflects extensive phosphorylation at 12+ sites, including residues targeted by PKD/PRKD1, PKD/PRKD2, MARK2 and MARK3 |
| additional bands at molecular weights other than ~103 kDa in some samples | HDAC7 is alternatively spliced into 10 annotated isoforms, so different transcripts can add bands of differing size |
| signal detected in both nuclear- and cytoplasmic-enriched fractions | HDAC7 shuttles between nucleus and cytoplasm, so either compartment can yield the ~103 kDa band |
| no smaller cleaved fragment migrating below the main band | HDAC7 has no signal peptide or propeptide, so there is no precursor-to-mature processing step to produce one |
| predicted mass (102.9 kDa, 952 aa) | sets the baseline expected migration position, matching the empirically observed ~103 kDa band |
| extensive phosphorylation (12 modified residues, including sites targeted by PKD/PRKD1, PKD/PRKD2, MARK2 and MARK3) | can cause a modest upward mobility shift or band broadening without materially changing the core molecular weight |
| 10 alternatively spliced isoforms | different transcripts can add extra bands larger or smaller than the canonical ~103 kDa band depending on which isoform is expressed |
| absence of a signal peptide or propeptide | no precursor-to-mature cleavage occurs, so no smaller processed fragment is expected |
| no glycosylation sites or disulfide bonds | rules out a smeared higher-molecular-weight glycoform or a ~200 kDa disulfide-linked dimer band under non-reducing conditions |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | HDAC7 expression is tissue-restricted and can be below detection in lysates from non- or low-expressing cell types | confirm with a positive-control tissue lysate (e.g. spleen, thymus, or placenta) known to express HDAC7 and increase total protein loaded |
| Band higher than expected | hyperphosphorylation at one or more of HDAC7's 12 known phosphosites shifts apparent mobility upward | treat lysate with a phosphatase (e.g. lambda phosphatase) before loading to collapse the shift toward the unmodified ~103 kDa position |
| Multiple bands | detection of more than one of the 10 annotated HDAC7 splice isoforms in the sample | compare band sizes against isoform-specific references and confirm the intended isoform using an epitope-mapped antibody |
| Broad smear instead of sharp band | heterogeneous phosphorylation states cause a population of HDAC7 molecules to migrate at slightly different rates | dephosphorylate the lysate prior to electrophoresis or resolve on a lower-percentage gel to sharpen the band |
| Weak or no signal | low endogenous HDAC7 abundance combined with nucleocytoplasmic shuttling can dilute signal in a whole-cell lysate | prepare a nuclear-enriched fraction, load more total protein, and keep lysates cold with protease/phosphatase inhibitors |
| Fragments below expected size | proteolytic degradation of this large 952-residue protein during lysate preparation | add protease inhibitors, keep samples on ice throughout lysis, and minimize freeze-thaw cycles |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for HDAC7, answered from its protein features.
BosterBio's HDAC7 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-HDAC7 antibody for Western blot represents the best-performing option available, widely cited across published studies and thoroughly validated through orthogonal approaches, including cross-validation against negative control tissue, ensuring confident, reproducible detection of HDAC7 in your samples.
Which to pick: Only one HDAC7 antibody is catalogued, PB9629, so it is the clear choice: it includes a genuine Western blot validation image showing detection in rat spleen tissue, confirming specificity and reliable performance for your blot.